Early research (Phase 1)Study completedNCT00493285
What this trial is testing
Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age
Who this might be right for
Respiratory Viral InfectionsRespiratory Syncytial Virus InfectionsParainfluenza Virus 3, Human
MedImmune LLC 49